The Federal Trade Commission (FTC) has finalized a consent order regarding Ascension Health Alliance's proposed $3.9 billion acquisition of AmSurg LLC. This decision marks a significant step in the regulatory process for the major healthcare merger.
The consent order addresses the terms and conditions under which Ascension, a prominent healthcare system, can proceed with its planned purchase of AmSurg, a leading provider of ambulatory surgery centers. The FTC's approval ensures compliance with antitrust regulations.
This finalization allows the substantial transaction, valued at $3.9 billion, to move forward, impacting the landscape of healthcare services.